Get our free email newsletter

EpiPens Recalled Due to Defective Part

Meridian Medical Technologies, the manufacturer of Mylan’s EpiPen-brand of epinephrine auto-injectors, has announced a voluntary recall of selected EpiPen lots due to safety concerns.

According to the company, a potential defect in a component of the auto-injector could make the device difficult to activate in an emergency situation, potentially resulting in significant health consequences for patients experiencing a life-threatening allergic reaction.

The EpiPens subject to recall were distributed by Mylan between December 2015 and July 2016, and impact the 0.3 mg and 0.15 mg strengths. Originally limited to the U.S., the recall has recently been expanded to include markets in Europe, Asia, North and South America.

- Partner Content -

Near and Far Field Measurements with a Vector Network Analyzer

For optimal performance in over-the-air RF systems, antennas must meet specific requirements. Performance parameters like size, wind-loading, environmental ruggedness, transmission pattern, bandwidth, and power handling capability should be considered. Methods of measuring the transmission (or reception) pattern that determines antenna gain with a VNA will be examined in this article.

Read additional details about this recall, including a listing of the affected lot numbers.

Related Articles

Digital Sponsors

Become a Sponsor

Discover new products, review technical whitepapers, read the latest compliance news, and check out trending engineering news.

Get our email updates

What's New

- From Our Sponsors -

Sign up for the In Compliance Email Newsletter

Discover new products, review technical whitepapers, read the latest compliance news, and trending engineering news.